Amantadine for motor fluctuations in advanced Parkinson's disease
Part of Brain & nervous system clinical trials.
This trial tests whether adding amantadine to your current Parkinson's medications can reduce
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had Parkinson's disease for at least 3 years.
- You should be between 30 and 80 years old.
- You must have motor fluctuations (periods where symptoms return) for at least 4 weeks before the study starts.
- You should be awake and in the 'off' state for at least 2 hours each day, including morning stiffness, despite taking your best current treatment.
- You must not have taken amantadine before.
- You must be able to complete a 'Hauser diary' to track your symptoms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether safinamide, an add-on medication for Parkinson's disease, can reduce chronic pain in people who also experience motor fluctuations (times when symptoms return between doses). It aims to see if this treatment can improve pain and quality of life.
This trial tests if using a wearable sensor can help doctors better adjust Parkinson's medications to reduce motor fluctuations (times when symptoms are not well controlled). It is for people with Parkinson's who have been on levodopa for at least 4 years and experience ups and downs in their movement control.
This study tests whether adding entacapone to Madopar (a common Parkinson's medication) safely improves symptoms in people with early-stage Parkinson's. It aims to see if the combination works better than Madopar alone.
This trial tests a new tablet (VG081821AC) for people with early-to-mid-stage Parkinson's disease who have not recently used levodopa. The goal is to see if it can improve movement symptoms safely.
This trial tests if taking daily amino acid supplements helps people with Parkinson's disease. You need to be on stable Parkinson's medication for at least 3 months.
This trial tests a new medication called Lu AF28996 to help reduce the periods when Parkinson's symptoms worsen throughout the day (called 'OFF times'). If you have motor fluctuations that are predictable and affecting your daily life, this study might help you experience fewer of these difficult periods.
Hear when a new Parkinson Disease (PD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.